See more : Hanwha General Insurance Co., Ltd. (000370.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Curexo Inc. (060280.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Curexo Inc., a leading company in the Medical – Specialties industry within the Healthcare sector.
You may be interested
- InspireMD, Inc. (NSPR) Income Statement Analysis – Financial Results
- Kawasaki Kisen Kaisha, Ltd. (KAIKY) Income Statement Analysis – Financial Results
- Pihlajalinna Oyj (PIHLIS.HE) Income Statement Analysis – Financial Results
- STORAGE-OH Co.,Ltd. (2997.T) Income Statement Analysis – Financial Results
- Nordstrom, Inc. (JWN) Income Statement Analysis – Financial Results
Curexo Inc. (060280.KQ)
Industry: Medical - Specialties
Sector: Healthcare
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 72.88B | 64.99B | 42.79B | 39.28B | 34.39B | 33.89B | 33.48B | 30.06B |
| Cost of Revenue | 53.58B | 51.60B | 34.46B | 30.56B | 29.49B | 28.27B | 27.93B | 28.61B |
| Gross Profit | 19.30B | 13.39B | 8.33B | 8.72B | 4.89B | 5.62B | 5.56B | 1.45B |
| Gross Profit Ratio | 26.48% | 20.61% | 19.47% | 22.19% | 14.23% | 16.58% | 16.60% | 4.82% |
| Research & Development | 7.60B | 5.19B | 4.84B | 4.30B | 5.83B | 4.08B | 648.55M | 19.41B |
| General & Administrative | 2.19B | 1.41B | 969.38M | 522.11M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 2.56B | 1.64B | 1.36B | 1.02B | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.75B | 7.11B | 5.24B | 3.86B | 3.37B | 5.37B | 4.35B | 22.54B |
| Other Expenses | 5.80B | 4.91M | -294.05M | -147.87M | -14.22M | -937.15M | -4.14M | -101.51M |
| Operating Expenses | 18.16B | 12.30B | 10.38B | 8.31B | 9.21B | 10.38B | 5.00B | 42.05B |
| Cost & Expenses | 71.75B | 63.90B | 44.84B | 38.87B | 38.70B | 38.65B | 32.93B | 70.66B |
| Interest Income | 1.33B | 629.54M | 82.85M | 127.07M | 212.81M | 322.71M | 50.23M | 43.56M |
| Interest Expense | 414.23M | 1.45B | 770.12M | 26.42M | 7.18M | 22.96M | 86.64M | 625.09M |
| Depreciation & Amortization | 1.59B | 1.25B | 982.64M | 642.13M | 669.36M | 528.00M | 308.33M | 3.19B |
| EBITDA | -2.75B | -236.42M | -567.20M | 1.09B | -3.65B | -28.87B | -16.49B | 4.43B |
| EBITDA Ratio | -3.78% | 3.60% | -2.48% | 2.67% | -10.60% | -12.49% | 2.58% | -124.45% |
| Operating Income | 1.14B | 1.09B | -2.04B | 407.35M | -4.32B | -4.76B | 556.43M | -40.60B |
| Operating Income Ratio | 1.56% | 1.68% | -4.78% | 1.04% | -12.55% | -14.05% | 1.66% | -135.07% |
| Total Other Income/Expenses | -5.90B | -4.02B | -502.87M | 11.48M | -2.56B | -25.58B | -17.44B | 39.23B |
| Income Before Tax | -4.76B | -2.93B | -2.32B | 418.83M | -6.88B | -29.42B | -16.88B | 616.07M |
| Income Before Tax Ratio | -6.53% | -4.51% | -5.42% | 1.07% | -20.00% | -86.81% | -50.43% | 2.05% |
| Income Tax Expense | 96.10M | 108.26M | 21.92M | 2.20M | 19.04B | 1.00 | -1.00 | 926.74K |
| Net Income | -4.86B | -3.04B | -2.34B | 416.63M | -25.92B | -29.42B | -16.88B | 24.15B |
| Net Income Ratio | -6.66% | -4.68% | -5.47% | 1.06% | -75.37% | -86.81% | -50.43% | 80.34% |
| EPS | -120.00 | -84.00 | -70.13 | 12.49 | -776.99 | -901.01 | -586.99 | 864.36 |
| EPS Diluted | -119.89 | -84.00 | -70.13 | 12.49 | -776.99 | -901.01 | -586.99 | 864.36 |
| Weighted Avg Shares Out | 40.47M | 36.20M | 33.39M | 33.37M | 33.36M | 32.65M | 28.76M | 27.94M |
| Weighted Avg Shares Out (Dil) | 40.50M | 36.20M | 33.39M | 33.37M | 33.36M | 32.65M | 28.76M | 27.94M |
No news found for: 060280.KQ
Source: https://incomestatements.info
Category: Stock Reports